In addition, insulin resistance causes hyperactivity of PLK-2, pSNCA and k-resistance SNCA levels in SH-SY5Y cells of PD and PLK2 inhibitors reverse the insulin resistance-mediated abnormalities [64]. The gene discussed is PLK2; the disease is Parkinson disease.